Post on 22-Nov-2014
description
-=6 HEADLINES
Indian Market
Indian equity markets up by 0.22%
Nifty up by 13.30 pts and settle at 6001.70
Sensex up by 51.10 pts at 19742.52
Bank Nifty up by 16.80 pts at 12725.50
Global Market
European markets were up with FTSE up by 6.93 closed at 6071,CAC up by 14.52 closed at 3719 and DAX down by 5.16 closed at 7727.
Dow future was down 10.00 closed at
13297.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY NEWSLETTER
9TH JANUARY 2013
HEADLINES
• Fitch renews warning on India's outlook;
rupee falls
• MOIL plans to up production, invest Rs
1,200 cr in phases
• Biocon gets DCGI approval to market
anti-psoriasis drug
• 25 bps rate cut won't push bonds further:
HDFC Bank
FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 8-Jan-13 3177.07 2289.69 887.38
DII 8-Jan-13 735.4 1763.52 -1028.12
NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6119 6076 6033 6017 5990 5974 5947 5904 5861
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
Key benchmark indices edged higher after Prime Minister Dr. Manmohan Singh said that despite
domestic constraints and challenges, India is confident that the strong economic fundamentals, backed
by sound policies, will enable the country to return to a higher growth path. Gains in European stocks
also supported domestic bourses.
The BSE Sensex was up 55.06 points or 0.28% to 19,746.48.
S&P CNX Nifty was up 14.45 points or 0.24% to 6,002.85.
Among the 30-share Sensex pack, 16 rose while the rest of them fell.
FMCG stocks gained on renewed buying. Godrej Consumer Products, Tata Global Beverages,
Hindustan Unilever, Dabur India and Nestle India gained by 0.04% to 1.02%. Pharma stocks edged
higher on renewed buying. Sun Pharmaceutical Industries rose 1.28%.Cipla gained 1.58% to Rs 430.
The stock hit record high of Rs 431.70 in intraday trade today, 8 January 2013.Dr Reddy's Laboratories
rose 1.05% to Rs 1,906.50. The stock hit record high of Rs 1,919.25 in intraday trade today, 8 January
2013. racle Financial Services Software jumped 3.18% to Rs 3376.65. The stock hit record high of Rs
3395 in intraday trade today, 8 January 2013.
STOCKS TO WATCH
TATA STEEL
LT
PETRONET
ONGC
SCRIPS IN BAN PERIOD
SUZLON
KTKBANK
RENUKA
IFCI
09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Consolidate
Strategy: Sell on rise
Support: 5960
Resistance: 6050
BANK NIFTY
Bank Nifty looks Consolidate
Strategy: Sell on rise
Support: 12650
Resistance: 12800
.0
GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH HINDUSTAN PETROLEUM
B SL TRIGERRED
CASH ITC S NOT
EXECUTED
FUTURE HCL S SL TRIGERRED
FUTURE ADANI POWER
B NOT
EXECUTED
UPCOMING RESULTS
GUJ NRE COKE
INDUSIND BANK
KITEX GARMENTS
YASH MANAGE
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
Reliance
Infra 567.10 2738.98 550.95 16.15 2.93
ITC 285.70 8956.38 279.05 6.65 2.38
HDFC 840.30 1812.48 822.95 17.35 2.11
Power Grid
116.45 4020.41 114.40 2.05 1.79
BHEL 243.90 2987.66 239.80 4.10 1.71
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
IDFC 180.40 4857.41 183.90 -3.50 -1.90
Tata Steel
433.35 3776.39 440.90 -7.55 -1.71
Wipro 398.15 1094.73 404.95 -6.80 -1.68
Sesa Goa 199.70 1443.32 202.65 -2.95 -1.46
Larsen & Toubro
1566.90 2653.80 1588.15 -21.25 -1.34
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
PETRONET BUY 167.20 168.20 169.70 166.20
LARSEN TOURBO SELL 1565.00 1561.00 1555.00 1569.00
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
TATA STEEL SELL 436.00 432.00 426.00 440.00
ONGC BUY 293.00 295.00 298.00 291.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.